June 16, 2025: On April 10, 2025, Arcturus Therapeutics announced that the FDA granted Fast Track Designation for their self-amplifying mRNA (sa-mRNA) vaccine candidate, ARCT-2304, designed for active immunization to protect against the H5N1 flu. This announcement caused many influencers in the health freedom movement to express strong concerns about the shedding of biosynthetic pathogens (aka – ‘variants’) if saRNA was used on the general public ‘to prevent an infectious disease,’ or during a pandemic.
Here’s the thing. saRNA was used on the general public during COVID-19 per Pfizer’s HHS/FDA submitted documents.
BioNTech’s investor relations (IR) presentations confirm these findings, as well as illustrate their dark, anti-human biowarfare plan.
Click this link for the original source of this article.
Author: Karen Kingston
This content is courtesy of, and owned and copyrighted by, https://karenkingston.substack.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
